Yahoo Finance • last month
We recently compiled a list of the 15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers.In this article, we are going to take a look at where Sage Therapeutics, Inc. (NASDAQ:SAGE) stands against the other Worst 52-Week Low Sto... Full story
Yahoo Finance • last month
We recently published a list of 15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers. In this article, we are going to take a look at where Sage Therapeutics, Inc. (NASDAQ:SAGE) stands against the other worst 52-week low stock... Full story
Yahoo Finance • 7 months ago
In this article, we will take a detailed look at the 12 Best Depressed Stocks To Buy in 2024. For a quick overview of the 5 such stocks, read our article5 Best Depressed Stocks To Buy in 2024. JPMorgan Chief Jamie Dimon, in his latest let... Full story
Yahoo Finance • 12 months ago
Wall Street is interested in updates on future developments, rather than the latest quarter's numbers. Continue reading... Full story
Yahoo Finance • 12 months ago
Sage Therapeutics Inc (NASDAQ:SAGE) reported Q3 2023 financial results with a strong financial foundation of $876 million in cash, cash equivalents and marketable securities. The company announced the expected wholesale acquisition cost of... Full story
Yahoo Finance • last year
NEW YORK, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against DigitalOcean Holdings, Inc. (NYSE: DOCN), and Sage Therapeutics, Inc... Full story
Yahoo Finance • last year
NEW YORK, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. (“Sage” or the “Company”) (NASDAQ: SAGE). Such investors are advised to contact Robert S. Willoughby a... Full story
Yahoo Finance • last year
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 28, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Sage Therapeutics, Inc. (NASDAQ: SAGE) investors that the firm has ini... Full story
Yahoo Finance • last year
SAN FRANCISCO, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Sage Therapeutics, Inc. (NASDAQ: SAGE) investors who suffered substantial losses to submit your losses now. Visit:www.hbsslaw.com/investor-fraud/sage Contact An Attor... Full story
Yahoo Finance • last year
NEW YORK, Aug. 27, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Blink Charging Co. (NASDAQ: BLNK), Lovesac Company (NASDAQ: LOVE), an... Full story
Yahoo Finance • last year
SAN FRANCISCO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Sage Therapeutics, Inc. (NASDAQ: SAGE) investors who suffered substantial losses to submit your losses now. Visit:www.hbsslaw.com/investor-fraud/sage Contact An Attor... Full story
Yahoo Finance • last year
In this article, we take a look at the 15 most important medical discoveries in history. You can skip our detailed analysis of the global medicine industry and go directly to the 5 Most Important Medical Discoveries in History. Medical di... Full story
Yahoo Finance • 2 years ago
CAMBRIDGE, Mass., March 08, 2023--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) notified the companies that the agency does not currently p... Full story
Yahoo Finance • 2 years ago
CAMBRIDGE, Mass., February 28, 2023--(BUSINESS WIRE)--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the Cowe... Full story
Yahoo Finance • 2 years ago
Zuranolone is being evaluated as a potential 14-day, rapid-acting, once-daily, oral medication to treat major depressive disorder (MDD) and postpartum depression (PPD) Depression is a public health issue with significant unmet medical need... Full story
Yahoo Finance • 2 years ago
Sage Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.... Full story
Yahoo Finance • 2 years ago
It's not possible to invest over long periods without making some bad investments. But you have a problem if you face massive losses more than once in a while. So consider, for a moment, the misfortune of Sage Therapeutics, Inc. (NASDAQ:SA... Full story
Yahoo Finance • 2 years ago
We analyzed the 100 largest public companies in Mass. by both stock price performance in 2021 and CEO compensation.... Full story
Yahoo Finance • 3 years ago
In this article, we will discuss 10 market-moving stocks to watch today. To take a look at some more stocks that are trending, go to 5 Market-Moving Stocks to Watch on Monday. Following April's tumultuous trading, investors are preparing... Full story